Genetics and environment in chronic inflammatory bowel diseases;Génétique et environnement dans les maladies inflammatoires chroniques de l'intestin

Revue Medicale de Liege

Volumn 67, Issue 5-6, 2012, Pages 298-304

  Louis, E ^a   Van Kemseke, C ^a   Latour, P ^a   Belaiche, J ^a   Reenaers, C ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Appendectomy; Environment; Genetics; Inflammatory bowel diseases; Intestinal flora; Smoking

Indexed keywords

ADAPTIVE IMMUNITY; APPENDECTOMY; CROHN DISEASE; ENVIRONMENTAL FACTOR; GENETIC VARIABILITY; HEREDITY; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; REVIEW; SMOKING; ULCERATIVE COLITIS;

ANIMALS; CHRONIC DISEASE; ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84863635814     PISSN: 0370629X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. -Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut, 1988, 29, 990-996.
2. Kim SC, Tonkonogy SL, Albright CA, et al. - Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology, 2005, 128, 891-906. (Pubitemid 40523542)
3. Molodecky NA, Soon IS, Rabi DM, et al. - Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 2012, 142, 46-54.
4. Satsangi J, Parkes M, Louis E, et al. - Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet, 1996, 14, 199-202. (Pubitemid 26338804)
5. Hugot JP, Chamaillard M, Zouali H, et al. - Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 2001, 411, 599-603. (Pubitemid 32531408)
6. Franke A, McGovern DP, Barrett JC, et al. - Genomewide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet, 2010, 42, 1118-1125.
7. Barrett JC, Hansoul S, Nicolae DL, et al. - Genomewide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet, 2008, 40, 955-962.
8. Anderson CA, Boucher G, Lees CW, et al. - Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet, 2011, 43, 246-252.
9. Calkins BM. - A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci, 1989, 34, 1841-1854. (Pubitemid 20018648)
10. Rubin DT, Hanauer SB. - Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol, 2000, 12, 855-862.
11. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. -Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis : a critical review. Inflamm Bowel Dis, 2002, 8, 277-286. (Pubitemid 34784981)
12. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. -Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut, 2006, 55, 205-211. (Pubitemid 43117279)
13. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. -High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 2004, 127, 412-421. (Pubitemid 39091889)
14. Sokol H, Pigneur B, Watterlot L, et al. - Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A, 2008, 105, 16731-16736.
15. Sandborn WJ, Feagan BG, Fedorak RN, et al. - Ustekinumab Crohn's Disease Study Group. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology, 2008, 135, 1130-1141.
16. Massey DC, Bredin F, Parkes M. - Use of sirolimus (rapamycin) to treat refractory Crohn's disease. Gut, 2008, 57, 1294-1296.
17. Kruis W, Fric P, Pokrotnieks J, et al. - Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut, 2004, 53, 1617-1623. (Pubitemid 39434105)
18. Gionchetti P, Rizzello F, Venturi A, et al. - Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis : a double-blind, placebo-controlled trial. Gastroenterology, 2000, 119, 305-309. (Pubitemid 30621980)